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extensive in adult patients with IPAH. The inﬂuence of these changes
on the development of PAH and on the outcome of this condition
deserves further study.
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OBJECTIVES We aimed to explore the application of intravascular
ultrasound (IVUS) to evaluate pulmonary vascular properties (PVPs)
and predict mortality in pulmonary arterial hypertension (PAH).
METHODS Patients (n¼51) with a systolic pulmonary arterial pressure
(SPAP) S40mmHg based on echocardiography were prospectively
enrolled. After underwent right heart catheterization (RHC) and IVUS, they
weredivided into 3 groups: PAHassociatedwith connective tissuediseases
(PAH-CTD) group (group1, n¼25), PAH due to other causes group (group2,
n¼15), and CTDs patients without PH (group3, n¼11). PAH group (groups 1
and 2) was divided into distal and proximal remodeling subtype based on
IVUS results. All patients were followed-up to compare the differences
among clinical variables, PVPs and survival rates.
RESULTS A total of 408 segments of pulmonary vessels were studied.
PAH group demonstrated a greater mean wall thickness (MWT)
(0.300.02, 0.330.02 vs. 0.210.02 mm, P<0.01) and a higher per-
centage of MWT (WTP) (13.62 0.59, 14.390.77 vs. 9.570.97%,
P<0.01) than group 3. Additionally, the pulmonary vascular me-
chanical properties (PVMPs) in PAH group were found to be worse
than those in group 3, with reduced compliance (8.850.8210-2,
6.280.6510-2 vs. 41.595.0210-2 mm2/mmHg, P<0.01) and
distensibility (0.830.09, 0.550.06 vs. 3.160.38%/mmHg, P<0.01),
higher elastic modulus (EM) (169.2515.10, 253.0022.11 vs.
43.784.27 mmHg, P<0.01) and stiffness index b (4.190.41,
5.180.34 vs. 2.390.27, P<0.01). Furthermore, an inverse exponen-
tial association was found between PVMPs and hemodynamic abnor-
malities, with R2 ranging from 0.544 to 0.777 (P<0.001). There was no
difference between groups 1 and 2 in survival curves. However, the
distal remodeling subtype had a higher mortality (22.73%) than the
proximal remodeling subtype with a hazard ratio of 10.14 (95% con-
ﬁdence interval: 1.686–61.00, P<0.05).
CONCLUSIONS IVUS may be useful in assessment of PH by evaluating
PVPs and predicting mortality. PAH group demonstrated worse PVPs
than CTDs patients without PH. PAH-CTD patients had better PVMPs
than PAH-due to other causes. There was no difference between PAH
groups in survival curves. However, distal remodeling subtype had a
higher mortality than proximal remodeling subtype.
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OBJECTIVES To investigate the clinical value of detecting cardiac
troponin T (cTnT) and plasma lactate (lac) for risk stratiﬁcation and
prognosis evaluation in patients with acute pulmonary embolism
(APE).
METHODS From January 2013 to Desember 2014, a total of 89 patients
were diagnosed with APE. All patients with a diagnosis of APE
established by lung scan or spiral computed tomography (CT) and
conﬁrmed by pulmonary angiography if necessary. Plasma troponin T
and lactate levels were tested at presentation. We considered lactate
values greater than or equal to 2 mmol/L and troponin T values greater
than or equal to 0.10 ng/mL to be abnormal. 89 patients with
conﬁrmed APE were divided into three groups according to the levels
of troponin T and plasma lactate: Group1 (n ¼ 16): cTnT < 0.1 ng/ml
and lac < 2.0 mmol/L; Group 2 (n ¼ 35): cTnT  0.1ng/ml or lac 
2.0 mmol/L; Group3 (n ¼ 38): cTnT  0.1 ng/ml and lac  2.0 mmol/L.
Analysis of troponin T and plasma lactate elevated risk stratiﬁcation
in patients with APE’s relationship with clinical prognosis.RESULTS Of the 89 patients included in the study, the mean age was
67 years (SD 10.2 years) and 45 (50.6%) were women. Clinical harmful
events were death caused by pulmonary embolism and clinical dete-
rioration deﬁned as progression to thrombolytic therapy, vasoactive
drugs, mechanical ventilation, shock, or cardiopulmonary resuscita-
tion. Patients with clinical harmful events in group 1, group 2 and
group 3 were 0 (0%) case, 7 (20.0%) cases, 21 (55.3%) cases respec-
tively and a signiﬁcant difference was observed (P <0.01). In the
group of proceeding clinical harmful events there were signiﬁcant
differences in troponin T and plasma lactate levels (p <0.01). 5 pa-
tients (5.6%) died in group 3and 0 (0%) case died in group 1 and group
2. All patients underwent thrombolysis treatment in group 3, 10 (28.6)
patients underwent thrombolysis treatment in group 2, and all pa-
tients underwent routine anticoagulation.
CONCLUSIONS Combinational detection of troponin T and plasma
lactate has important value for early risk stratiﬁcation and prognosis
evaluation in patients with APE. Patients with pulmonary embolism
elevated troponin T and plasma lactate level are at high risk of death
and adverse outcome.
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OBJECTIVES Pulmonary arterial hypertension (PAH) is a female pre-
dominant disease. However, women have preserved right ventricle
function and better survival compared with men suffered from PAH.
This “sex paradox” indicates sex hormones may contribute signiﬁ-
cantly to the pathogenesis of PAH. We sought to assess the relation-
ship between serum concentration of sex hormone and hemodynamic
parameters in men with idiopathic PAH (IPAH).
METHODS In the observational study, we recruited 98 male IPAH
patients (mean  SD age, 4118 years), at Cardio-Pulmonary Circula-
tion center (Shanghai Pulmonary Hospital), from June 2008 to October
2014. The study included 85 age-matched healthy male control sub-
jects. Serum concentrations of estradiol (E2), testosterone (TT) and
progesterone (P) were measured using immunoassays, and the clin-
ical, functional, and hemodynamic compromises were collected at
enrollment.
RESULTS Compared with the healthy controls, serum E2 concentra-
tions were increased, and serum TT, P concentrations were decreased
in IPAH patients [E2: 153 (99-215) vs 121 (97-140) pmol/l, p ¼ 0.002; TT:
8.8 (4.6-21.0) vs 15.8 (12.0-19.5) pmol/l, p ¼ 0.007; P: 0.32 (0.22-0.43)
vs 0.48 (0.33-0.63) ng/ml, p < 0.001]. There were correlations between
P and HR, WHO functional class (FC), 6MWD, serum brain natriuretic
peptide, pericardial effusion, pulmonary vascular resistance and car-
diac output (all P<0.05). There were no correlations between E2 or TT
and the above parameters. At linear regression analysis, P was the
predictor most associated to WHO FC, 6MWD, PVR elevation and CO
reduction. Furthermore, P was only the independent predictor most
associated with PVR elevation after adjustment for age, BSA and WHO
FC by multivariate analysis (R2¼0.346, 95% IC: -15.635w-0.986,
P¼0.027).
CONCLUSIONS This work demonstrates serum P concentrations were
decreased in male IPAH patients. It’s an independent predictor for
PVR elevation and could estimate the severity of men with IPAH.
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OBJECTIVES Pulmonary arterial hypertension (PAH) is a syndrome
resulting from a restricted ﬂow through the pulmonary arterial cir-
culation, giving rise to increased pulmonary vascular resistance and
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Galectin-3 (Gal-3) induced endothelial cell morphogenesis and regu-
lated myoﬁbroblast activation. The aim of this study was to determine
the diagnostic utility of circulating Gal-3 as a potential biomarker of
disease severity in PAH.
METHODS Gal-3 was measured in plasma from 31 patients with PAH,
diagnosed from right heart catheterization, as well as 18 healthy
controls by ELISA. Besides, chronic hypoxia induced pulmonary hy-
pertension models were established in Sprague-Dawley rats. Lung
tissues were collected for histological analysis including Gal-3
lung qualitative localization by immunohistochemistry. Total mRNA
was extracted from pulmonary arteries in rats, then quantitative
PCR was performed with total cellular mRNA to measure Gal-3
expression.
RESULTS Plasma level of Gal-3 was signiﬁcantly decreased in PAH
patients compared with healthy controls (p < 0.001). Within the
subgroups the correlation was given only by idiopathic PAH (IPAH)
patients statistically expressed the lower level of Gal-3 (n ¼ 16, p <
0.001). Gal-3 levels inversely correlated with mean pulmonary arterial
pressure (mPAP) (r ¼ -0.57, p ¼ 0.021) and pulmonary vascular resis-
tance (PVR) (r ¼ -0.55, p ¼ 0.027), and correlated with cardiac output
(r ¼ 0.530, p ¼ 0.035) in IPAH patients. A Gal-3 cut off value less than
1.765 ng/ml yielded 93% sensitivity and 88% speciﬁcity for IPAH pa-
tients. Immunohistochemistry method identiﬁed Gal-3 was distrib-
uted throughout the adventitia of the pulmonary arterioles. The
expression of Gal-3 mRNA was signiﬁcantly down-regulated in the
pulmonary arteries from lung tissue samples in pulmonary hyper-
tension rats.
CONCLUSIONS Gal-3 might be involved in the pathogenesis of PAH,
and plasma Gal-3 could serve as a promising new biomarker of diag-
nosis and disease severity in IPAH.
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OBJECTIVES To observe the effects of adipose tissue-derived stem
cells (ADSC) and adiponectin (APN) gene-modiﬁed ADSC trans-
plantation in monocrotaline (MCT) induced pulmonary arterial hy-
pertensive (PAH) rats.
METHODS Eighty SD rats were randomly divided into normal control
group (NC group), PAH group, ADSC group (ADSC group), empty len-
tiviral vector infected ADSC group (ADSC-V group) and APN gene
modiﬁed ADSC (ADSC-APN group). PAH group, ADSC group, ADSC-V
group and ADSC-APN group were given 40mg/kg MCT by intraperi-
toneal injection. Fourteen days after MCT injection, 1.0106 cells/ml
suspension, including with ADSC, empty lentiviral vector infected
ADSC or APN gene modiﬁed ADSC, were injected into ADSC group,
ADSC-V group or ADSC-APN group through left jugular vein, respec-
tively. Three weeks after cells transplantation, mean pulmonary
arterial pressure (mPAP), right ventricular hypertrophy index (RVHI),
vasoconstriction and diastolic function, wall to lumen thickness
(WT%) and area (WA%) of pulmonary artery were detected. Serum
APN levels were assayed by ELISA. The expression of eNOS in pul-
monary artery was detected by immunohistochemical staining. Right
heart function was evaluated by echocardiography. Plasmic metabo-
lites were detected by NMR-based metabonomics technology. The
expressions of bone morphogenetic protein-2 (BMP2), p-Smad1/5/8,
Smad1/5/8/9, p-AMPK and AMPK were detected by western blot after
incubation with different combination of Smad inhibitor and AMPK
inhibitor on pulmonary arterial smooth muscle cells (PASMCs) of PAH
rats. Cells proliferation were detected by CCK-8 kit.
RESULTS Transplantation of ADSC and APN gene-modiﬁed ADSC
could signiﬁcantly decrease mPAP, RVHI, WT% and WA%; improve
endothelium-dependent and endothelium-independent relaxation of
pulmonary artery. Meanwhile, eNOS expression in the intima of pul-
monary artery was signiﬁcantly upregulated. Echocardiography
showed that right ventricular structure and function were restored.
Compared with ADSC alone transplantation, APN gene-modiﬁed ADSC
transplantation therapy is better than ADSC transplantation alone.
Transplantation of APN gene-modiﬁed ADSC could signiﬁcantly
decrease the levels of serum glucose and serum lactate and increase
the levels of serum alanine. APN upregulated the BMP2 expression ofPASMCs in a dose-dependent manner. BMP inhibitor could reduce the
expression of BMP2 and p-Smad1/5/8 induced by APN, and promote
cells proliferation. AMPK inhibitor could reduces the expression of p-
AMPK and BMP2 induced by APN.
CONCLUSIONS ADSC and APN gene-modiﬁed ADSC could increase
the expression of eNOS, improve vasodilation, reduce pulmonary
artery remodeling, decreased mPAP, and improve right ventri-
cular function. The transplantation of APN gene-modiﬁed ADSC
was better than ADSC transplantation alone. APN gene-modiﬁed
ADSC could improve Warburg effect and alanine metabolism in
MCT-induced PAH rats. The mechanism that APN inhibits prolifera-
tion of PASMCs may be related to the activation of AMPK and BMP/
Samd pathway.
GW26-e0216
Systemic arteriovenous shunt porcine model for chronic pulmonary
hypertension Functional and Structural Assessment of the Changes in the
Pulmonary Circulation
Xuemei Li, Ji Wu
Department of Ultrasound, the First Afﬁliated Hospital of Guangxi
Medical University
OBJECTIVES Altered pulmonary vascular reactivity is a source of
morbidity and mortality for children with congenital heart defects
(CHD) and increased pulmonary blood ﬂow. The aim of this study was
to determine the effects of systemic arteriovenous shunting on the
structure and reactivity of the pulmonary circulation in piglets.
METHODS A shunt between the left carotid artery and the jugular
vein (CA-JV) was created in 1 month old piglets. Hemodynamic indices
were determined periodically by echocardiography to evaluate the
pulmonary artery pressure (PAP) and the pulmonary vascular resis-
tance (PVR). Animals were sacriﬁced at the end of the experiment,
18months after the surgical anastomosis. The lung tissue and plasma
were prepared for histopathological and immunohistochemical
analysis.
RESULTS The pulmonary arterial systolic pressure (PASP) and mean
the pulmonary arterial pressure (MPAP) increased gradually (P<0.05)
in the process of establishing the chronic pulmonary hypertension
model, as did the pulmonary artery acceleration time (PAAT), pul-
monary artery deceleration time (PADT) and right ventricle ejection
time (RVET). The ratio of PAAT/RVET increased slightly ﬁrst and then
decreased (P<0.05). PAAT, PAAT/RVET showed a good correlation
with PASP (r ¼ -0.81, -0.72). The pulmonary vascular resistance was
signiﬁcantly higher in the shunt-group compared with that of sham-
group, while it became higher and higher 10 months after the shunting
operations. PAAT and the value of the ratio PAVCR ¼ VPA/(VTIPA 
HR) i.e. pulmonary peak velocity (VPA) divided by its velocity time
integral (VTIPA) multiplied by the heart rate (HR), showed a good
correlation with PVR (r ¼ -0.68,0.79). Morphometric analysis of the
pulmonary vascular bed revealed an increase in the number of pe-
ripheral muscular arteries, together with an increase in pulmonary
arterial medial thickness in the shunt group. The concentration of 3’,
5’-cyclic guanosine monophosphate (cGMP) in both the lung tissue
and the plasma was enhanced in the shunt-group compared with the
controls group.
CONCLUSIONS Systemic arteriovenous shunting leads to both struc-
tural and functional alteration of the pulmonary vasculature. PAAT
and PAAT/RVET were sensitive indicators to evaluate pulmonary ar-
tery hypertension (PAH); PAAT and PAVCR ¼ VPA/(VTIPA  HR) were
established as sensitive indicators to evaluate PVR. The elevation of
PAP is attributed to the increased PVR. We determined that, with the
end-to-side anastomosis of the left carotid artery and the jugular vein
in one month old piglets, a good model of pulmonary hypertension
with increased pulmonary blood ﬂow can be built.
GW26-e0096
In rats with ALI/ARDS, do lung ultrasound results agree with
CT imaging results?
Huan Ma, Liheng Guo, Lei Wang, Shuai Mao, Yi Ren, Wenhui Li,
Minzhou Zhang
Guangdong Provincial Hospital of Chinese Medicine
OBJECTIVES Lung sonography can diagnose Acute Lung Injury/Acute
Respiratory Distress Syndrome (ALI/ARDS) in humans and large ani-
mals. To date, no published articles have reported the identiﬁcation of
